Glucocorticoids as adjunctive therapy for severe myelosuppression induced by combined immune checkpoint inhibitor and chemotherapy: a case report and literature review - Scorecard - MDSpire
Advertisement
Glucocorticoids as adjunctive therapy for severe myelosuppression induced by combined immune checkpoint inhibitor and chemotherapy: a case report and literature review
Clinical Scorecard: Utilization of Glucocorticoids as Supportive Treatment for Severe Myelosuppression Following Combined Immune Checkpoint Inhibitor and Chemotherapy: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Key Mechanisms
Immune-mediated myelosuppression due to interactions between ICI and chemotherapy.
Target Population
Care Setting
Key Highlights
Differential diagnosis is crucial for identifying immune-mediated myelosuppression.
Guideline-Based Recommendations
Diagnosis
Management
Administer high-dose glucocorticoids alongside standard supportive care, with specific dosing recommendations.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
High-dose glucocorticoids can lead to full hematologic restoration, as evidenced in the case study.
Clinical Best Practices
Monitor for signs of infection and other complications related to glucocorticoid use.
